GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 701 filers reported holding GLAXOSMITHKLINE PLC in Q3 2014. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $205,000 | -11.3% | 5,350 | 0.0% | 0.11% | -13.1% |
| Q3 2016 | $231,000 | -0.4% | 5,350 | 0.0% | 0.12% | +1.7% |
| Q2 2016 | $232,000 | +7.4% | 5,350 | 0.0% | 0.12% | +4.3% |
| Q1 2016 | $216,000 | -54.3% | 5,350 | -54.4% | 0.12% | -61.9% |
| Q4 2015 | $473,000 | -33.3% | 11,725 | -36.4% | 0.30% | -40.1% |
| Q3 2015 | $709,000 | -54.7% | 18,450 | -50.9% | 0.50% | -51.0% |
| Q2 2015 | $1,565,000 | -35.3% | 37,575 | -28.3% | 1.03% | -35.5% |
| Q1 2015 | $2,417,000 | +10.3% | 52,375 | +2.1% | 1.60% | +12.1% |
| Q4 2014 | $2,192,000 | +66.8% | 51,300 | +79.4% | 1.42% | +62.6% |
| Q3 2014 | $1,314,000 | +85.9% | 28,600 | +116.4% | 0.88% | +87.6% |
| Q2 2014 | $707,000 | -1.8% | 13,215 | -2.0% | 0.47% | -6.4% |
| Q1 2014 | $720,000 | -5.3% | 13,490 | -5.3% | 0.50% | -6.4% |
| Q4 2013 | $760,000 | – | 14,250 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
| Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
| KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
| Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
| EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
| Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
| Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
| Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
| Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
| CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |